Amgen buying deCODE Genetics for $415 million

THOUSAND OAKS, Calif. — Biotech drug maker Amgen is buying human genetics research and analytics company deCODE Genetics for $415 million.

DeCODE, based in Reykjavik, Iceland, has discovered genetic risk factors for dozens of diseases ranging from cardiovascular disease to cancer

“DeCODE Genetics has built a world-class capability in the study of the genetics of human disease. This capability will enhance our efforts to identify and validate human disease targets,” Amgen CEO Robert Bradway said in a statement on Monday.

Amgen’s board has approved the deal, which does not need regulatory approval. The transaction is expected to close before year’s end.

Shares of Amgen, which is based in Thousand Oaks, Calif., slipped 12 cents to $88.20 in premarket trading. Its shares peaked for the past year at $89.95 in mid-October. They fell as low as $57.14 almost a year ago.

Among Amgen’s products are the anemia drugs Aranesp and Epogen.

More in Herald Business Journal

Why real estate investors are watching self-driving cars closely

With decisions on real estate made years in advance, could self-driving cars change how we live?

More than 60 Boeing 737s per month: Can suppliers keep up?

There was lots of talk this week about the prudence and pressures of soaring production rates.

Developer proposes an 18-story building in Lynnwood

It would be the second-tallest in the county and include apartments with retail space.

Even as stock markets shook, many investors held steady

Older investors were buying stocks, but at a lower rate than their younger counterparts.

Snohomish County business licenses

PLEASE NOTE: Business license information is obtained monthly from the Washington Secretary… Continue reading

New Everett mayor speaks out about business in city, region

Q&A: Cassie Franklin on what can be done to get Boeing to build the 797 here and attract new industries.

Aerospace analyst explains how he’ll help state’s Boeing bid

Richard Aboulafia will deliver a report on Washington’s strengths and weaknesses in landing the 797.

Air passenger traffic growing faster than airplane capacity

“Our customers are in a good place,” a Boeing marketing executive says of the airlines.

Load up: Cheesecake Factory plans Lynnwood location

The chain restaurant is listed as a tenant in new development at Alderwood mall.